No abstract available
MeSH terms
-
Administration, Oral
-
Animals
-
Biological Availability
-
Bone Density / drug effects
-
Breast Neoplasms / pathology
-
Cell Division / drug effects
-
Cholesterol / blood
-
Estrogen Antagonists / administration & dosage
-
Estrogen Antagonists / metabolism
-
Estrogen Antagonists / pharmacokinetics
-
Estrogen Antagonists / pharmacology*
-
Ethinyl Estradiol / metabolism
-
Female
-
Humans
-
Hypolipidemic Agents / metabolism
-
Hypolipidemic Agents / pharmacology
-
Neoplasms, Hormone-Dependent / pathology
-
Organ Size / drug effects
-
Ovariectomy
-
Pyrrolidines / administration & dosage
-
Pyrrolidines / metabolism
-
Pyrrolidines / pharmacokinetics
-
Pyrrolidines / pharmacology*
-
Rats
-
Receptors, Estrogen / agonists*
-
Receptors, Estrogen / antagonists & inhibitors*
-
Tetrahydronaphthalenes / administration & dosage
-
Tetrahydronaphthalenes / metabolism
-
Tetrahydronaphthalenes / pharmacokinetics
-
Tetrahydronaphthalenes / pharmacology*
-
Tumor Cells, Cultured
-
Uterus / drug effects
Substances
-
Estrogen Antagonists
-
Hypolipidemic Agents
-
Pyrrolidines
-
Receptors, Estrogen
-
Tetrahydronaphthalenes
-
Lasofoxifene
-
Ethinyl Estradiol
-
Cholesterol